Information Provided By:
Fly News Breaks for June 27, 2016
CLSD, SWKS, NH, GWPH, SE
Jun 27, 2016 | 10:23 EDT
Catch up on the today's top five analyst initiations with this list compiled by The Fly: 1. Spectra Energy (SE) initiated with an Outperform at RBC Capital by analyst Elvira Scotto, who has a $39 price target on the stock. The analyst believes Spectra can deliver solid, highly visible cash-flow and dividend growth over the next several years underpinned by a robust backlog of demand-pull growth projects. 2. GW Pharmaceuticals (GWPH) initiated with a Sell at Janney Capital by analyst Ken Trbovich, who has a $40 price target on the stock. The analyst said GW awaits imminent results of Phase 3 trial results in Lennox-Gastaut Syndrome. Unfortunately, even if the data in LGS is good, Trbovich thinks its valuation exceeds the commercial prospects for drugs that treat orphan epilepsy indications.3. NantHealth (NH) initiated with a Buy at Canaccord by analyst Richard Close, who has a $17 price target following its recent IPO. The firm sees NantHealth as a leader in precision medicine, bringing to market an innovative cancer diagnostic test coupled with a cloud-based offering to drive increased value. NantHealth was also initiated with an Outperform at FBR Capital and Cowen and an Ovweight at First Analysis, with analyst Joseph Munda saying he believes the company has assembled a powerful combination of information technology and advanced molecular diagnostics and views its leadership as exceptionally well qualified. 4. Skyworks (SWKS) initiated with an Underweight at Morgan Stanley by analysts led by Craig Hettenbach, who put a $61 price target on the stock. The analyst said Skyworks is far behind Broadcom on business diversification and customer concentration will likely pressure the stock's multiple. 5. Clearside Biomedical (CLSD) initiated with an Outperform at Cowen by analyst Boris Peaker, who noted the company is developing a novel device that enables the administration of drugs to the back of the eye with minimal front of the eye exposure which can be used for indications like AMD, DME, and glaucoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For SE;GWPH;NH;SWKS;CLSD From the Last 2 Days
SE
Apr 24, 2024 | 05:49 EDT
Loop Capital upgraded Sea Limited to Buy from Hold with a price target of $92, up from $59. The stock's valuation pressure the last two years is mainly because of aggressive competition and share loss to TikTok, the analyst tells investors in a research note. However, the firm says the recent announcement of a commission rate increase by the combined TikTok-Tokopedia, its first move since merging to satisfy Indonesian regulators, "has sparked a revaluation" Sea shares. Loop believes this signals that the shift to sustained profitable growth is "finally underway" and serves as a significant catalyst for revaluation of Sea Limited. With "competitive rationality" setting in, Loop moved from its "broken stock" valuation framework for Sea.